Skip to content
PeptideRank
Rankings
Menu

Every price, read off the source

What a peptide prescription actually costs, checked line by line.

PeptideRank reads every provider's own pricing page and prints what it found — the ongoing rate, not the sign-up rate; the dose the cheap number actually buys; and the pharmacy question most of them decline to answer. Dated, sourced, and the ranking criteria are printed on the page.

See the rankingsHow we earn

  • 2

    ranked provider boards

  • 4

    providers researched

  • 4

    full write-ups

What is on this site

Where to get it

Sermorelin, prescribed properly.

Sermorelin and the GH-secretagogues are not over-the-counter, not safely. We looked at who actually prescribes them, what a compounding pharmacy adds to the price, and which providers hide the real cost until checkout.

3 providers compared

See the ranking

The GLP-1 board

Tirzepatide, ranked on the real monthly cost.

Compounded tirzepatide's advertised price and its true no-commitment monthly cost are not always the same number. We checked every provider's own pricing page, prepay tiers included, before ranking anyone.

4 providers compared

See the ranking

The write-ups

Every provider, in full.

Each company on a board gets its own review: what the ongoing price really is, what the intake does and does not tell you, who fills the prescription, and the one thing we would want to know before handing over a card.

4 write-ups

Read the reviews

How a ranking is decided

Disclosure first, price second.

How we earn

Compounded peptide pricing is quoted to be hard to compare: a “from” figure that only applies at the smallest dose, a first-month rate that is not the ongoing one, a pharmacy nobody will name. Of the 4 providers we have checked so far, just 1 states which pharmacy fills its prescriptions and what that pharmacy's FDA category is. That gap is the ranking.

  1. We read the seller's own pageEvery figure on a board came off that company's public pricing page, on a date printed beside it. Not a press release, not another comparison site, not a number a merchant sent us.
  2. Pharmacy disclosure ranks firstA provider that names the pharmacy filling its prescriptions and states that pharmacy's FDA category outranks one that will not — before price is considered at all.
  3. Then, and only then, priceProviders that tie on disclosure are ordered by their own advertised price, low to high. A “starting at” floor is labelled as a floor, never reprinted as if it were a monthly cost.

Compare before you commit

Compare every provider, on the same criteria.

Pick the question you actually have.

Every provider, reviewed· 4 write-ups

Who's behind this

Marcus WebbPricing & Provider Research Editor

Marcus Webb researches and verifies peptide and GLP-1 telehealth provider pricing for PeptideRank, checking every claim against the provider's own published terms.

Editorial policyAbout PeptideRankHow we earn

  • Read off the provider's own page

    Every price here was taken from the company's own public pricing page, on a date we print beside it. Never from a press release, a comparison table, or another site.

  • Silence is a finding

    When a provider will not say what a higher dose costs, or will not name the pharmacy that fills it, we print that instead of estimating around it.

  • Straight about the money

    We say plainly how we are funded: some links here are affiliate links, and a commission may follow. The write-up beside a provider is what should decide it, not the payout.